Meredith’s legal practice reflects her long-standing interest in biology and biotechnology. As part of her practice, she counsels life sciences and biotechnology companies on intellectual property issues arising in commercial transactions, strategic collaborations, licensing arrangements, and corporate transactions. Drawing on her background in biology, biotechnology, chemistry, and regulatory affairs, Meredith advises clients on patent and FDA-related matters, helping them assess and manage intellectual property risks in connection with investments, acquisitions, and business-critical agreements.
Another aspect of Meredith’s practice involves conducting IP diligence for acquisitions and investments in pharmaceutical and biotechnology companies. She prepares assessments of patent portfolios, evaluates the strengths and vulnerabilities of key intellectual property assets, analyzes ongoing litigation and regulatory developments, and advises clients on issues affecting the value and commercialization of innovative technologies.
Meredith’s transactional counseling is informed by substantial experience litigating complex patent disputes in the pharmaceutical, biotechnology, and agricultural technology sectors. She has represented clients in federal district court litigation, including Hatch-Waxman and trade secret matters, and in disputes involving patent license agreements.
